Pharvis InnoCare and Meducation K held the 3rd Retigen Live Seminar on October 23rd.
Retigen is a high-purity atelocollagen product with the telopeptides that can cause immune reactions removed. Lecturer Dr. 김민승 described it as "a true anti-aging solution that directly acts on human tissues to activate the skin's natural regenerative capabilities."
The product maintains a transparent formulation through impurity removal, providing high safety and immediate elasticity improvement effects when injected into the dermal layer.
Team leader 윤선영 stated that since its launch in 2023, it has established trust through numerous clinical data sets and is positioning itself as a new standard in anti-aging regenerative medicine.
Source: 머니투데이